Consultant
Siddhartha Sivaramakrishnan represents multinational companies and investors on cross-border business transactions, including M&A, investments, financings, and regulatory and compliance matters.
He also counsels on US and UK capital markets and public company matters. He has deep experience across EMEA and APAC advising corporations, shareholders and financial sponsors on effective legal and commercial solutions that propel success. Siddhartha has particular sector expertise in energy and renewables; healthcare and life sciences; financial services and technology; and data protection.
Siddhartha has been recognised in all major directories, including Chambers, Legal 500 and International Financial Law Review. He has been ranked as an International A-list Lawyer by India Business Law Journal.
Advised Innovative International Acquisition Corp., a Nasdaq-listed SPAC, on its merger agreement with India-based Zoomcar, an emerging market focused car sharing platform at an implied enterprise value of US$456 million.
Advised The Coca-Cola Company in its US$730 million divestiture of its minority interest in its Thailand bottling business to a subsidiary of the Hong Kong-listed conglomerate Swire Group.
Advised HIG Capital on the Asia elements of its US$375 million acquisition of the spine business of Nasdaq-listed Zimvie Inc.
Advised the United Nations in establishing the Global Fund for Refugees, a first-of-its-kind US$500 million shariah-compliant global fund supporting the developmental and humanitarian needs of forcibly displaced people.
Advised a leading stablecoin issuer on its minority investment in a Singapore- and Israel-based payment systems provider.
Advised a leading social media platform on cybersecurity and data governance matters across multiple Asian jurisdictions.
Advised a leading US healthcare provider on its joint venture and related licensing arrangements in Singapore.
Advised a global aerospace manufacturer on data breaches in certain Asian jurisdictions.
Advised a US data platform on its services agreement with an Indian telecoms major.
Advised a neo-finance bank on its investment in a low carbon energy technology business.
Advised a Baltic gaming operator on its restructuring of its outstanding senior secured notes and related consent solicitation.
Advised a US investment fund on its listing on the Luxembourg Stock Exchange of notes representing interests in the fund.
Advised Kotak, Citi, Nomura and Haitong on the US$872 million IPO on the Bombay Stock Exchange and Rule 144A/Regulation S global offering of Gland Pharma, a leading generic injectables manufacturer majority owned by global pharmaceutical major Shanghai Fosun Pharma.
Advised Credit Suisse, Bank of America and UBS as joint sponsors on the US$1.31 billion SEC-registered global offering and secondary listing on the Hong Kong Stock Exchange of New Oriental Education and Technology, China’s largest private educational service provider.
Advised Dalrymple Bay Infrastructure, a Brookfield-owned coal terminal, on the US securities law aspects of its US$656 million IPO on the Australian Stock Exchange and Rule 144A/Regulation S global offering. Bank of America, Citi and Credit Suisse were the joint lead managers.
Advised Wijaya Karya, an Indonesian engineering and construction major, on its IDR5.4 trillion (US$400 million) global offering of rupiah-denominated, dollar-settled Komodo bonds, the largest such issuance as of its date. BNP, HSBC, Mandiri and MUFG were the initial purchasers.
Advised Khazanah, the Malaysian sovereign wealth fund, on its US$500 million Regulation S offering of exchangeable bonds. CIMB, Credit Suisse and J.P. Morgan were the joint lead managers.